Inhibitor Therapeutics, Inc. SEC filings INTI

Inhibitor Therapeutics, Inc. has 724 filings in SEC EDGAR's recent list, going back to Jul 21, 1997. Its latest annual report, Form 10-K, was filed on Mar 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 18, 2026 (officer or director change, shareholder vote results). The company's fiscal year ends on December 31.

Inhibitor Therapeutics, Inc. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change, Shareholder vote results
Sep 18, 2026 Sep 15, 2026
DEF 14A Proxy statement Aug 17, 2026 Aug 17, 2026
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Regulation FD disclosure
Apr 1, 2026 Apr 1, 2026
8-K Current report
Other events
Apr 1, 2026 Apr 1, 2026
10-K Annual report Mar 26, 2026 Dec 31, 2025
8-K Current report
Material agreement
Feb 24, 2026 Feb 24, 2026
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Material agreement, Officer or director change
Oct 27, 2025 Oct 24, 2025
UPLOAD Letter from the SEC Sep 15, 2025 —
10-Q Quarterly report Aug 13, 2025 Jun 30, 2025
CORRESP Letter to the SEC Jul 22, 2025 —
UPLOAD Letter from the SEC Jul 17, 2025 —
10-Q Quarterly report May 14, 2025 Mar 31, 2025
10-K Annual report Mar 28, 2025 Dec 31, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
10-K Annual report Mar 29, 2024 Dec 31, 2023
8-K Current report
Material agreement, Other events
Dec 14, 2023 Dec 12, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Oct 18, 2023 Oct 13, 2023
8-K Current report
Officer or director change, Bylaw or fiscal year change
Aug 29, 2023 Aug 23, 2023
10-Q Quarterly report Aug 11, 2023 Jun 30, 2023
8-K Current report
Officer or director change
May 31, 2023 May 31, 2023
10-Q Quarterly report May 15, 2023 Mar 31, 2023
10-K Annual report Mar 31, 2023 Dec 31, 2022
8-K Current report
Material agreement, Agreement ended, Change in control, Officer or director change
Dec 19, 2022 Dec 13, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Other events
Sep 15, 2022 Sep 9, 2022
10-Q Quarterly report Aug 12, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Jun 3, 2022 Jun 1, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
10-K Annual report Mar 30, 2022 Dec 31, 2021
8-K Current report
Material agreement, New debt
Jan 18, 2022 Jan 13, 2022
10-Q Quarterly report Nov 12, 2021 Sep 30, 2021
10-Q Quarterly report Aug 13, 2021 Jun 30, 2021
10-Q Quarterly report May 14, 2021 Mar 31, 2021
10-K Annual report Mar 26, 2021 Dec 31, 2020
8-K Current report
Officer or director change
Jan 6, 2021 Dec 31, 2020
8-K Current report
Material agreement, New debt
Dec 17, 2020 Dec 12, 2020
10-Q Quarterly report Nov 16, 2020 Sep 30, 2020
8-K Current report
Officer or director change
Sep 23, 2020 Sep 17, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
8-K Current report
Officer or director change
Jun 30, 2020 Jun 28, 2020
8-K Current report
Other events
Jun 8, 2020 Jun 4, 2020
8-K Current report
Material agreement, New debt
May 6, 2020 May 3, 2020
10-Q Quarterly report May 1, 2020 Mar 31, 2020
8-K Current report
Officer or director change
Apr 16, 2020 Apr 10, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019
8-K Current report
Officer or director change, Other events
Jan 3, 2020 Dec 31, 2019
DEF 14C Information statement Dec 5, 2019 Dec 5, 2019
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Officer or director change, Other events
Oct 31, 2019 Oct 30, 2019
8-K Current report
Material agreement, Agreement ended
Aug 27, 2019 Aug 21, 2019
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure, Other events
Aug 20, 2019 Aug 19, 2019
10-Q Quarterly report Aug 12, 2019 Jun 30, 2019
8-K Current report
Regulation FD disclosure, Other events
Jul 17, 2019 Jul 17, 2019
8-K Current report
Officer or director change
Jul 1, 2019 Jun 30, 2019
8-K Current report
Other events
Jun 19, 2019 Jun 14, 2019
DEF 14C Information statement Jun 3, 2019 Jun 3, 2019
PRE 14C Filing May 24, 2019 May 24, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
EFFECT Filing Apr 30, 2019 —
POS AM Filing Apr 26, 2019 —
8-K Current report
Other events
Apr 15, 2019 Apr 15, 2019
CT ORDER Filing Apr 1, 2019 —
10-K Annual report Mar 7, 2019 Dec 31, 2018
8-K Current report
Regulation FD disclosure, Other events
Feb 13, 2019 Feb 11, 2019
DEF 14C Information statement Jan 8, 2019 Dec 21, 2018
8-K Current report
Material agreement, Officer or director change
Dec 31, 2018 Dec 31, 2018
PRE 14C Filing Dec 28, 2018 Dec 21, 2018
DEF 14C Information statement Dec 21, 2018 Dec 21, 2018
8-K Current report
Material agreement, Officer or director change, Bylaw or fiscal year change, Other events
Dec 17, 2018 Dec 17, 2018
10-Q Quarterly report Nov 14, 2018 Sep 30, 2018
8-K Current report
Regulation FD disclosure
Nov 5, 2018 Nov 5, 2018
10-Q Quarterly report Jul 23, 2018 Jun 30, 2018
8-K Current report
Unregistered share sale, Other events
Jul 10, 2018 Jul 6, 2018
10-Q Quarterly report May 1, 2018 Mar 31, 2018
EFFECT Filing Apr 17, 2018 —
POS AM Filing Apr 4, 2018 —
10-K Annual report Feb 16, 2018 Dec 31, 2017
CT ORDER Filing Jan 22, 2018 —
8-K Current report
Material agreement, Unregistered share sale, Other events
Jan 11, 2018 Jan 8, 2018
8-K Current report
Shareholder vote results
Dec 20, 2017 Dec 18, 2017
DEF 14A Proxy statement Nov 13, 2017 Dec 18, 2017
10-Q Quarterly report Oct 31, 2017 Sep 30, 2017
8-K Current report
Other events
Oct 5, 2017 Oct 5, 2017
10-Q Quarterly report Jul 31, 2017 Jun 30, 2017
8-K Current report
Other events
Jul 27, 2017 Jul 25, 2017
8-K Current report
Other events
May 30, 2017 May 30, 2017
10-Q Quarterly report May 8, 2017 Mar 31, 2017
EFFECT Filing Apr 25, 2017 —
POS AM Post - effective amendment no. 1 to form s-1 Apr 21, 2017 —
10-K Annual report Feb 17, 2017 Dec 31, 2016
8-K Current report
Regulation FD disclosure
Jan 24, 2017 Jan 24, 2017
DEF 14C Information statement Dec 5, 2016 Dec 5, 2016
8-K Current report
Officer or director change, Other events
Dec 2, 2016 Nov 30, 2016
8-K Current report
Material agreement, Officer or director change
Nov 28, 2016 Nov 22, 2016
8-K Current report
Change in control
Nov 8, 2016 Nov 2, 2016
10-Q Quarterly report Oct 31, 2016 Sep 30, 2016
S-8 Employee stock plan registration Oct 24, 2016 —
10-Q Quarterly report Aug 12, 2016 Jun 30, 2016
424B3 Prospectus Jul 26, 2016 —
EFFECT Filing Jul 22, 2016 —
CORRESP Letter to the SEC Jul 21, 2016 —
S-1/A Amended registration statement Jul 21, 2016 —
CORRESP Letter to the SEC Jul 18, 2016 —
S-1/A Amended registration statement Jul 18, 2016 —
UPLOAD Letter from the SEC Jul 6, 2016 —
S-1 Registration statement Jun 17, 2016 —
8-K Current report
Material agreement, Unregistered share sale
Jun 1, 2016 May 25, 2016
8-K Current report
Bylaw or fiscal year change
May 26, 2016 May 20, 2016
10-Q Quarterly report May 13, 2016 Mar 31, 2016
8-K Current report
Material agreement, Unregistered share sale
May 3, 2016 May 3, 2016
DEF 14C Information statement Apr 25, 2016 Apr 25, 2016
D Filing Apr 22, 2016 —
8-K Current report
Material agreement, Unregistered share sale
Apr 15, 2016 Apr 11, 2016
PRE 14C Preliminary information statement Apr 12, 2016 Apr 12, 2016
RW Request for withdrawal Mar 22, 2016 —
S-1/A Amended registration statement Feb 23, 2016 —
10-K Annual report Feb 1, 2016 Dec 31, 2015
8-K Current report
Material agreement
Dec 22, 2015 Dec 17, 2015
S-1 Registration statement Dec 17, 2015 —
CT ORDER Filing Nov 13, 2015 —
CT ORDER Filing Nov 13, 2015 —
10-Q Quarterly report Nov 4, 2015 Sep 30, 2015
8-K Current report
Material agreement
Sep 9, 2015 Sep 2, 2015
10-Q Quarterly report Aug 14, 2015 Jun 30, 2015
EFFECT Filing Aug 10, 2015 —
424B3 Prospectus Aug 10, 2015 —
CORRESP Letter to the SEC Aug 6, 2015 —
S-1/A Amended registration statement Jul 22, 2015 —
DEF 14C Information statement Jun 16, 2015 Jun 16, 2015
PRE 14C Preliminary information statement Jun 3, 2015 Jun 15, 2015
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
May 21, 2015 May 15, 2015
10-Q Quarterly report May 13, 2015 Mar 31, 2015
10-K Annual report Feb 13, 2015 Dec 31, 2014
CT ORDER Filing Oct 17, 2014 —
DEF 14C Information statement Oct 14, 2014 Oct 14, 2014
10-Q Quarterly report Oct 10, 2014 Sep 30, 2014
PRE 14C Preliminary information statement Oct 3, 2014 Oct 3, 2014
UPLOAD Letter from the SEC Sep 26, 2014 —
S-1 Registration statement Sep 17, 2014 —
8-K Current report
Material agreement, Officer or director change
Sep 9, 2014 Sep 4, 2014
CT ORDER Filing Sep 8, 2014 —
10-Q Quarterly report Aug 13, 2014 Jun 30, 2014
8-K Current report
Bylaw or fiscal year change, Other events
Jul 24, 2014 Jul 18, 2014
8-K Current report
Material agreement, Unregistered share sale, Officer or director change
Jun 30, 2014 Jun 24, 2014
10-Q Quarterly report May 12, 2014 Mar 31, 2014
10-K Annual report Apr 15, 2014 Dec 31, 2013
NT 10-K Notification of late filing Mar 31, 2014 Dec 31, 2013
8-K Current report
Material agreement
Mar 11, 2014 Mar 5, 2014
8-K Current report
Material agreement
Dec 23, 2013 Dec 17, 2013
10-Q Quarterly report Nov 14, 2013 Sep 30, 2013
CT ORDER Filing Oct 10, 2013 —
8-K Current report
Material agreement, Bylaw or fiscal year change, Regulation FD disclosure
Sep 10, 2013 Sep 3, 2013
10-Q Quarterly report Sep 6, 2013 Jun 30, 2013
8-K Current report
Auditor change
Aug 28, 2013 Aug 13, 2013
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change
Aug 16, 2013 Aug 12, 2013
10-Q Quarterly report May 20, 2013 Mar 31, 2013
10-K Annual report May 20, 2013 Dec 31, 2012
NT 10-Q Notification of late filing May 15, 2013 Mar 31, 2013
8-K Current report
Bankruptcy
Apr 18, 2013 Apr 18, 2013
NT 10-K Notification of late filing Apr 1, 2013 Dec 31, 2012
8-K Current report
Auditor change
Mar 28, 2013 Mar 27, 2013
8-K Current report
Auditor change
Feb 4, 2013 Feb 4, 2013
10-Q Quarterly report Nov 19, 2012 Sep 30, 2012
NT 10-Q Notification of late filing Nov 13, 2012 Sep 30, 2012
10-Q Quarterly report Aug 17, 2012 Jun 30, 2012
NT 10-Q Form 12b-25 Aug 14, 2012 Jun 30, 2012
10-Q Quarterly report May 15, 2012 Mar 31, 2012
10-K Annual report Apr 16, 2012 Dec 31, 2011
NT 10-K Notification of late filing Mar 30, 2012 Dec 31, 2011
8-K Current report
Acquisition or sale of assets
Jan 5, 2012 Dec 30, 2011
10-Q Quarterly report Nov 14, 2011 Sep 30, 2011
10-Q Quarterly report Aug 22, 2011 Jun 30, 2011
NT 10-Q Notification of late filing Aug 12, 2011 Jun 30, 2011
10-Q Quarterly report May 23, 2011 Mar 31, 2011
NT 10-Q Notification of late filing May 16, 2011 Mar 31, 2011
10-K Annual report May 4, 2011 Dec 31, 2010
15-12B/A Form 15-12b/a Mar 22, 2011 —
15-12B Deregistration Mar 14, 2011 —
8-K Current report
Other events
Mar 11, 2011 Dec 31, 2010
8-K Current report
Other events
Mar 9, 2011 Dec 31, 2010
8-K Current report
Bankruptcy
Jan 25, 2011 Jan 20, 2011
NO ACT Auto-generated paper document Jan 14, 2011 Jan 4, 2011
NO ACT Auto-generated paper document Dec 28, 2010 Nov 18, 2010
10-Q Quarterly report Nov 15, 2010 Sep 30, 2010
PREM14A Prem 14a Oct 28, 2010 Dec 20, 2010
10-Q Quarterly report Oct 25, 2010 Jun 30, 2010
8-K Current report
Officer or director change
Jul 28, 2010 Jul 22, 2010
10-Q Quarterly report May 13, 2010 Mar 31, 2010
8-K Current report
Listing notice
Apr 13, 2010 Apr 9, 2010
25-NSE Delisting notice Apr 9, 2010 —
10-K Annual report Mar 31, 2010 Dec 31, 2009
PRE 14A Preliminary proxy statement Feb 2, 2010 Feb 2, 2010
8-K Current report
Listing notice
Jan 21, 2010 Jan 21, 2010
8-K Current report
Material agreement
Jan 4, 2010 Dec 28, 2009

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
INTI (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Tampa, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1042418
Former names
HedgePath Pharmaceuticals, Inc. (until Aug 12, 2019); COMMONWEALTH BIOTECHNOLOGIES INC (until May 20, 2013)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.